There is also evidence for age‐dependent expression of ACE2 in the nasal epithelium, with progressively higher levels in adulthood than in children, which may also correlate with lower infectivity of COVID‐19 in younger patients [4]. This evidence concerns the gene ACE2 and COVID-19.